Ascendis Pharma A/S
ASND
ASND
272 hedge funds and large institutions have $14.3B invested in Ascendis Pharma A/S in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 108 increasing their positions, 105 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.9% less ownership
Funds ownership: 104.44% → 100.54% (-3.9%)
10% less funds holding
Funds holding: 302 → 272 (-30)
42% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 59
Holders
272
Holding in Top 10
16
Calls
$341M
Puts
$59M
Top Buyers
| 1 | +$1.01B | |
| 2 | +$202M | |
| 3 | +$101M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$63M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$44.8M |
Top Sellers
| 1 | -$866M | |
| 2 | -$248M | |
| 3 | -$116M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$99.3M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$83.4M |
